Wordt geladen...
Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report
Discontinuation of denosumab is associated with the increase of bone turnover markers to above-baseline levels (so-called rebound in bone turnover) and rapid bone loss. Several studies have reported vertebral fractures (VFs), particularly multiple spontaneous clinical VFs (MSCVFs), occurring after d...
Bewaard in:
| Gepubliceerd in: | Bone Rep |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7284126/ https://ncbi.nlm.nih.gov/pubmed/32548215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2020.100288 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|